IL17A and synovial sarcoma: Both Sakai et al. and Fei et al. reported that the majority infiltrating cells in the salivary glands of SS patients were CD4+ T cells, with a predominant expression of IL-17 [56, 57], which could be modified by immunosuppressive treatment [57].